These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 37343993)

  • 1. Changes in cancer screening process in primary care during the covid-19 pandemic.
    Atadağ YB; Türkmen AT; Öksüz A; Keten HS; Aydin MR
    Saudi Med J; 2023 Jun; 44(6):621-624. PubMed ID: 37343993
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cancer Screening Disparities Before and After the COVID-19 Pandemic.
    Lofters AK; Wu F; Frymire E; Kiran T; Vahabi M; Green ME; Glazier RH
    JAMA Netw Open; 2023 Nov; 6(11):e2343796. PubMed ID: 37983033
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of the COVID-19 pandemic on population-based cancer screening, a nationwide retrospective study in Taiwan.
    Su CH; Hsu PS; Lin CS
    BMC Health Serv Res; 2023 Aug; 23(1):878. PubMed ID: 37605162
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A population-based survey of self-reported delays in breast, cervical, colorectal and lung cancer screening.
    Gunn CM; Berrian K; Weiss JE; Tosteson AAN; Hasson RM; Di Florio-Alexander R; Peacock JL; Rees JR
    Prev Med; 2023 Oct; 175():107649. PubMed ID: 37517458
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The impact of COVID-19 on screening for colorectal, gastric, breast, and cervical cancer in Korea.
    Park H; Seo SH; Park JH; Yoo SH; Keam B; Shin A
    Epidemiol Health; 2022; 44():e2022053. PubMed ID: 35760396
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of COVID-19 pandemic on breast and cervical cancer screening in Denmark: A register-based study.
    Nonboe MH; Napolitano G; Schroll JB; Vejborg I; Waldstrøm M; Lynge E
    Elife; 2023 Mar; 12():. PubMed ID: 36943035
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Japanese cancer screening programs during the COVID-19 pandemic: Changes in participation between 2017-2020.
    Machii R; Takahashi H
    Cancer Epidemiol; 2023 Feb; 82():102313. PubMed ID: 36508964
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Effect of Disability and Social Determinants of Health on Breast and Cervical Cancer Screenings During the COVID-19 Pandemic.
    Rolle LD; Chery MJ; Larson M; Lopez-Pentecost M; Calfa CJ; Schlumbrecht MP; Crane TE
    Prev Chronic Dis; 2024 Jan; 21():E05. PubMed ID: 38271492
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A national quality improvement study identifying and addressing cancer screening deficits due to the COVID-19 pandemic.
    Joung RH; Nelson H; Mullett TW; Kurtzman SH; Shafir S; Harris JB; Yao KA; Brajcich BC; Bilimoria KY; Cance WG
    Cancer; 2022 Jun; 128(11):2119-2125. PubMed ID: 35307815
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Changes in Cancer Screening in the US During the COVID-19 Pandemic.
    Fedewa SA; Star J; Bandi P; Minihan A; Han X; Yabroff KR; Jemal A
    JAMA Netw Open; 2022 Jun; 5(6):e2215490. PubMed ID: 35657622
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Changes in Screening Test Volume in the National Breast and Cervical Cancer Early Detection Program during the COVID-19 Pandemic, 2020-2022.
    Bermudez Y; DeGroff A; Miller J; Kenney K; Lockhart J; Joseph D; Richardson L
    Int J Environ Res Public Health; 2024 Jun; 21(7):. PubMed ID: 39063394
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Oncological organized screening programmes in the COVID-19 era: an Italian survey on accrued delays, reboot velocity, and diagnostic delay estimates].
    Mantellini P; Battisti F; Armaroli P; Giubilato P; Ventura L; Zorzi M; Battagello J; Sassoli de Bianchi P; Senore C; Zappa M
    Epidemiol Prev; 2020; 44(5-6 Suppl 2):344-352. PubMed ID: 33412828
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Examining the perceived impact of the COVID-19 pandemic on cervical cancer screening practices among clinicians practicing in Federally Qualified Health Centers: A mixed methods study.
    Fuzzell L; Lake P; Brownstein NC; Fontenot HB; Whitmer A; Michel A; McIntyre M; Rossi SL; Kajtezovic S; Vadaparampil ST; Perkins R
    Elife; 2023 Sep; 12():. PubMed ID: 37664989
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changes in cancer screening before and during COVID-19: findings from the Korean National Cancer Screening Survey 2019 and 2020.
    Trinh TTK; Lee YY; Suh M; Jun JK; Choi KS
    Epidemiol Health; 2022; 44():e2022051. PubMed ID: 35638224
    [TBL] [Abstract][Full Text] [Related]  

  • 15. County-Level Social Vulnerability and Breast, Cervical, and Colorectal Cancer Screening Rates in the US, 2018.
    Bauer C; Zhang K; Xiao Q; Lu J; Hong YR; Suk R
    JAMA Netw Open; 2022 Sep; 5(9):e2233429. PubMed ID: 36166230
    [TBL] [Abstract][Full Text] [Related]  

  • 16. COVID-19 and inequities in colorectal and cervical cancer screening and diagnosis in Washington State.
    Amram O; Amiri S; Robison J; Pflugeisen CM; Monsivais P
    Cancer Med; 2022 Aug; 11(15):2990-2998. PubMed ID: 35304835
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of COVID-19 on Primary Care Quality Measures in an Academic Integrated Health System.
    Kim E; Kojima N; Vangala S; Dermenchyan A; Lambrechts S; Grossman M; Han M; Croymans DM
    J Gen Intern Med; 2022 Apr; 37(5):1161-1168. PubMed ID: 35083647
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Breast Cancer Screening During the COVID-19 Pandemic in the United States: Results From Real-World Health Records Data.
    Chung A; Chen Q; Curry W; Felix T; Tuan WJ
    Ann Fam Med; 2024; 22(3):208-214. PubMed ID: 38806260
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Breast cancer and cervical cancer: a comparison of the period before and during the COVID-19 pandemic.
    Stevanato KP; Santos LD; Pelloso FC; Borghesan DHP; Consolaro MEL; de Almeida R; Huber IMT; Egger P; Alarcão ACJ; de Souza RR; Ribeiro HF; Camparoto CW; Bitencourt MR; Borba PB; Silva LL; de Barros Carvalho MD; Pelloso SM
    BMC Womens Health; 2024 Sep; 24(1):485. PubMed ID: 39227848
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Trends in breast and prostate cancer screening and diagnostic procedures during the COVID-19 pandemic in central Massachusetts.
    Epstein MM; Sundaresan D; Fair M; Fouayzi H; Warner ET; Garber LD; Gurwitz JH; Field TS
    Cancer Causes Control; 2022 Oct; 33(10):1313-1323. PubMed ID: 35933572
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.